Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04872179 · ClinicalTrials.gov registry record
International Registry of Patients With Alpha Thalassemia
A clinical trial of Alpha-Thalassemia and Alpha Thalassemia Major, sponsored by University of California, San Francisco.
- Recruiting
- Registry status
- 500
- Enrollment target
- 1
- Study location
NCT04872179: Recruiting study of Alpha-Thalassemia and Alpha Thalassemia Major, sponsored by University of California, San Francisco.
NCT04872179 is a study of Alpha-Thalassemia and Alpha Thalassemia Major that is actively recruiting participants, run by University of California, San Francisco. The registered enrollment target is 500 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04872179, a study of Alpha-Thalassemia and Alpha Thalassemia Major, is actively recruiting participants, sponsored by University of California, San Francisco.
- RECRUITING
- Registry status
- 500 participants
- Enrollment target
- 1
- Study location
Study Summary
This is an international prospective registry of patients with Alpha thalassemia to understand the natural history of the disease and the outcomes of fetal therapies, with the overall goal of improving the prenatal management of patients with Alpha thalassemia.
Primary Outcome
Number of fetuses diagnosed with alpha thalassemia who survive to birth, compared to number of fetuses diagnosed with alpha thalassemia who have fetal demise or are terminated in utero. This is measured in number of fetuses alive at birth divided by number of all fetuses.
Conditions Studied
Study Locations (1)
California
- University of California San Francisco - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2017-01 |
| Est. Completion | 2037-01 |
What NCT04872179 shows while recruiting
NCT04872179 is an observational study that tracks outcomes without assigning an intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap.
The record links to 3 conditions, with Alpha-Thalassemia appearing as the primary indexed condition, and to 0 interventions.
NCT04872179 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT04872179 about?
NCT04872179 is a clinical study titled "International Registry of Patients With Alpha Thalassemia". This is an international prospective registry of patients with Alpha thalassemia to understand the natural history of the disease and the outcomes of fetal therapies, with the overall goal of improving the prenatal management of patients with Alpha thalassemia.
What is the current status of trial NCT04872179?
This trial is currently recruiting. The enrollment target is 500 participants. The study started on 2017-01. Estimated completion is 2037-01.
What conditions does trial NCT04872179 study?
This clinical trial studies the following conditions: Alpha-Thalassemia, Alpha Thalassemia Major, Alpha Thalassemia Minor.
Who is sponsoring clinical trial NCT04872179?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04872179 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alpha-Thalassemia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001230 · 500 participants
Host Response to Infection and Treatment in Filarial Diseases
- NCT00001529 · 500 participants
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
- NCT00697411 · 500 participants
Study of Selected X-Linked Disorders: Aicardi Syndrome
- NCT00903110 · 500 participants
Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia